Session 2 : ER Positive Braest Cancer and others

ER Positive Braest Cancer and others By Rajiv Sarin

Chairpersons :

Ramesh Nimmagadda, N K Warrier

Speaker :

Rajiv Sarin

A Phase III trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy( CREATE-X, JBCRG 04)

Author: Lee S-J

Conference: SABCS

Consensus on breast cancer cell lines classification for an effective and efficient clinical decision making

Author: H. Milioli

Conference: IMPAKT